USING OF NARROW-WAVE ULTRAVIOLET THERAPY IN PATIENTS WITH PSORIASIS TO IMPROVE THE QUALITY OF TREATMENT

Psoriasis is one of the most common chronic inflammatory recurrent multifactorial skin diseases dominated by genetic etiology [1,5,9], which is characterized by hyperproliferation of epidermal cells, impaired keratinization against the background of an inflammatory reaction in the dermis, as well as damage to nails, joints and hair. parts of the head [5,8]. According to clinical and epidemiological studies, the prevalence of this disease in the world varies from 0.5 to 4.6%, regardless of gender, age and ethnicity [1,4,6,8]. The proportion of this pathology in the general structure of skin diseases reaches from 1 to 40%. On the basis of clinical signs, the following types of psoriasis are distinguished: chronic plaque psoriasis; psoriasis with psoriatic arthritis; pustular, erythroderma, or guttate psoriasis, palmar - plantar psoriasis.